Search results for " biologic" in Articles / App Notes
Article
The Future of Biopharma
Some of the biopharmaceutical trends coming in 2013 support a future vision that includes:
• increasing number of global biopharma facilities
• more biological products, many with smaller nich…
Article
Addressing the Challenges in Downstream Processing Today and Tomorrow
Most commercial prophylactic vaccines are not well-characterized biologicals from a regulatory perspective because of their inherent complexity and/or poorly understood mechanism of action. In additio…
Article
Pushing the Barriers in Next-Gen Antibody Development
Continued development of new and next-generation antibodies is spurred by the increasing demand for more effective and custom-tailored biologic therapies. In particular, bispecific antibodi…
Article
Genetic Vaccine Platforms Demonstrate Their Potential
Genetic vaccines, while faster to develop than proteins, are still biologic products that require cell culture and sophisticated technology for development and manufacturing at both clinical and comme…
Article
Manage HCPs and Enhance Your Route to Market
Click here to read more >>
Host cell protein (HCP) management is critical to biologics development—and getting it wrong could delay your development cycle. Learn how the right HCP strategy can e…
Article
Biomanufacturing: Demand for Continuous Bioprocessing Increasing
Some of these technologies also support the increasing demand for biologics that may be called for in smaller quantities.
Figure 2 shows the economic commitment decision-makers are focusing on …
Article
2019’s Top Bioprocessing Trends and What to Expect in 2020
2019 proved to be an exciting year for biopharmaceutical developers and process engineers, filled with both advancements and lessons. Considering how far the industry has come, what direction will 2…
Article
Science Focus Fuels Successful Process Development for Startups
“There are no established protocols for how to go about process development for cell therapies, unlike for conventional biologics and small-molecule drugs. We are engineering patient cells to produce …
Article
Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
Another significant challenge with biosimilars as well as other biological products is that of standardizing the Fc receptor binding. Fc receptors can be activating, or inhibitory, or without any effe…
Article
Achieving Process Balance with Perfusion Bioreactors
…with 100% product transmission under typical process conditions used in the continuous production of biologics,” he notes.
Sartorius Stedim Biotech is working with Repligen to develop integration…